APA (7th ed.) Citation

Criscuolo, E., De Sciscio, M. L., De Cristofaro, A., Nicoara, C., Maccarrone, M., & Fezza, F. (2023). Computational and Experimental Drug Repurposing of FDA-Approved Compounds Targeting the Cannabinoid Receptor CB1. Pharmaceuticals (14248247), 16(12), 1678. https://doi.org/10.3390/ph16121678

Chicago Style (17th ed.) Citation

Criscuolo, Emanuele, Maria Laura De Sciscio, Angela De Cristofaro, Catalin Nicoara, Mauro Maccarrone, and Filomena Fezza. "Computational and Experimental Drug Repurposing of FDA-Approved Compounds Targeting the Cannabinoid Receptor CB1." Pharmaceuticals (14248247) 16, no. 12 (2023): 1678. https://doi.org/10.3390/ph16121678.

MLA (9th ed.) Citation

Criscuolo, Emanuele, et al. "Computational and Experimental Drug Repurposing of FDA-Approved Compounds Targeting the Cannabinoid Receptor CB1." Pharmaceuticals (14248247), vol. 16, no. 12, 2023, p. 1678, https://doi.org/10.3390/ph16121678.